IL10 and cancer: Collectively, these data provide evidence that cancer type-specific TME-associated factors govern the ability of IL-10 to act as either a pro- or an anti-tumoral cytokine, and highlight the need for further studies to clarify the functions of IL-10 in specific pathological contexts.